Detailed information about the 100 most recent patent applications.
| Application Number | Title | Filing Date | Disposal Date | Disposition | Time (months) | Office Actions | Restrictions | Interview | Appeal |
|---|---|---|---|---|---|---|---|---|---|
| 19244937 | EMULSIFICATION DEVICES AND METHODS FOR CRYSTALLINE LENS REMOVAL | June 2025 | September 2025 | Allow | 3 | 0 | 0 | Yes | No |
| 19048877 | DEVICE AND METHOD FOR GENERATING A CHANNEL IN AN EYE TISSUE LAYER FOR TREATMENT OF OCULAR DISORDERS | February 2025 | October 2025 | Allow | 8 | 2 | 0 | No | No |
| 18393411 | DIRECTIONAL STENT FOR ACCESSING EXTRAVASCULAR SPACES | December 2023 | January 2026 | Allow | 25 | 0 | 0 | Yes | No |
| 18288336 | PUNCHING-TYPE IRIDOTOMY INSTRUMENT | October 2023 | October 2025 | Allow | 24 | 1 | 0 | No | No |
| 18486110 | RETRACTABLE CAP ACTUATION FOR AN INTRAOCULAR LENS CARTRIDGE | October 2023 | September 2025 | Allow | 23 | 0 | 0 | Yes | No |
| 18355857 | VIBRATION INDUCED MEMBRANE RUPTURE | July 2023 | November 2023 | Allow | 4 | 1 | 0 | Yes | No |
| 18209061 | SURGICAL INSTRUMENTS WITH ARTICULATING SHAFTS | June 2023 | February 2026 | Allow | 32 | 1 | 0 | Yes | No |
| 18320484 | HAPTIC OPTIC MANAGEMENT SYSTEM UTILIZING EDGE ROLLERS | May 2023 | February 2026 | Allow | 33 | 1 | 0 | Yes | No |
| 18113577 | METHODS AND SYSTEMS FOR ALIGNING A COMMISSURE OF A PROSTHETIC HEART VALVE WITH A COMMISSURE OF A NATIVE VALVE | February 2023 | October 2023 | Allow | 8 | 0 | 1 | No | No |
| 18112924 | ERGONOMIC FORCEPS TOOL | February 2023 | December 2025 | Allow | 34 | 0 | 0 | No | No |
| 18098291 | DEVICE AND METHOD FOR CREATING A CHANNEL IN SOFT TISSUE | January 2023 | June 2023 | Allow | 5 | 0 | 0 | Yes | No |
| 18093564 | DEVICES AND METHODS FOR CONTROLLED DELIVERY OF A STENT | January 2023 | October 2025 | Allow | 34 | 1 | 0 | Yes | No |
| 18084041 | TISSUE EXPANDERS AND METHODS OF USE THEREOF | December 2022 | June 2025 | Abandon | 30 | 1 | 0 | No | No |
| 18079240 | AORTIC BIOPROSTHESIS AND SYSTEMS FOR DELIVERY THEREOF | December 2022 | October 2025 | Allow | 34 | 2 | 0 | Yes | No |
| 18001387 | INJECTOR ASSEMBLY FOR INSERTING AN INTRAOCULAR LENS AND INJECTOR | December 2022 | July 2023 | Allow | 8 | 1 | 0 | No | No |
| 18001377 | INJECTOR ASSEMBLY FOR INSERTING AN INTRAOCULAR LENS AND INJECTOR | December 2022 | June 2023 | Allow | 6 | 0 | 0 | Yes | No |
| 18077897 | IMPLANT HAVING FILAMENT LIMBS OF AN ADJUSTABLE LOOP DISPOSED IN A SHUTTLE SUTURE | December 2022 | September 2025 | Allow | 33 | 1 | 0 | Yes | No |
| 18058045 | FOLDING DEVICE FOR INTRAOCULAR LENS INJECTOR | November 2022 | October 2025 | Allow | 35 | 0 | 1 | Yes | No |
| 17992445 | THROMBECTOMY APPARATUSES | November 2022 | August 2025 | Allow | 32 | 1 | 0 | Yes | No |
| 18055671 | HAPTIC OPTIC MANAGEMENT SYSTEM UTILIZING ROTATING CAMS | November 2022 | February 2026 | Allow | 39 | 1 | 1 | Yes | No |
| 17977079 | DEVICE AND METHOD FOR TREATING VASCULAR OCCLUSION | October 2022 | June 2024 | Abandon | 19 | 2 | 0 | No | No |
| 17968656 | THROMBECTOMY SYSTEMS AND DEVICES AND METHODS OF USING THE SAME | October 2022 | May 2025 | Abandon | 31 | 1 | 0 | No | No |
| 17819990 | HAPTIC MANAGEMENT FOR SURGICAL IMPLANTS | August 2022 | February 2026 | Allow | 42 | 1 | 0 | Yes | No |
| 17888454 | ATHERECTOMY SYSTEM WITH GUIDEWIRE DETECTION | August 2022 | March 2025 | Allow | 31 | 0 | 1 | Yes | No |
| 17886824 | INTRAVASCULAR CATHETER HAVING AN EXPANDABLE INCISING PORTION AND EMBOLIC PROTECTION DEVICE | August 2022 | August 2025 | Allow | 37 | 1 | 0 | Yes | No |
| 17886605 | INTRAVASCULAR CATHETER HAVING AN EXPANDABLE INCISING PORTION AND EMBOLIC PROTECTION DEVICE | August 2022 | August 2025 | Allow | 36 | 2 | 0 | Yes | Yes |
| 17883295 | METHODS AND SYSTEMS FOR TREATMENT OF ACUTE ISCHEMIC STROKE | August 2022 | June 2024 | Allow | 22 | 3 | 0 | Yes | No |
| 17818055 | INTRAOCULAR LENS INJECTOR | August 2022 | February 2025 | Allow | 31 | 1 | 0 | Yes | No |
| 17817728 | IOL INJECTOR WITH AUTOMATIC DRIVER OR ASSISTED MANUAL DRIVE FORCE | August 2022 | November 2025 | Allow | 39 | 1 | 1 | Yes | No |
| 17875142 | INJECTOR ASSEMBLY FOR INSERTING AN INTRAOCULAR LENS | July 2022 | December 2024 | Allow | 28 | 2 | 1 | Yes | No |
| 17868076 | TISSUE EXPANSION DEVICES, SYSTEMS AND METHODS | July 2022 | August 2024 | Allow | 25 | 0 | 0 | Yes | No |
| 17856435 | INTRAVASCULAR CATHETER HAVING AN EXPANDABLE INCISING PORTION | July 2022 | June 2025 | Allow | 36 | 2 | 0 | Yes | No |
| 17833969 | SCALP ROLLER AND METHOD FOR TATTOOING | June 2022 | July 2025 | Allow | 37 | 2 | 0 | Yes | No |
| 17828749 | DEVICE AND METHOD FOR CREATING A CHANNEL IN SOFT TISSUE | May 2022 | December 2022 | Allow | 7 | 1 | 0 | Yes | No |
| 17826280 | TRANS-VAGINAL CUFF ANCHOR AND METHOD OF DEPLOYING SAME | May 2022 | September 2024 | Allow | 27 | 0 | 0 | Yes | No |
| 17825074 | CLOT RETRIEVER CLEANING FOR REINSERTION | May 2022 | September 2024 | Allow | 28 | 0 | 0 | Yes | No |
| 17825537 | METHODS, COMPOSITIONS, AND DEVICES FOR THE OCCLUSION OF CAVITIES AND PASSAGEWAYS | May 2022 | April 2023 | Allow | 11 | 1 | 0 | Yes | No |
| 17748523 | METHODS AND SYSTEMS FOR TREATMENT OF ACUTE ISCHEMIC STROKE | May 2022 | August 2022 | Allow | 3 | 0 | 0 | No | No |
| 17745708 | DEVICES AND METHODS FOR CREATING A CAPSULORHEXIS | May 2022 | December 2025 | Allow | 43 | 3 | 0 | Yes | No |
| 17729699 | LEFT ATRIAL APPENDAGE OCCLUDER DEVICE | April 2022 | February 2023 | Allow | 10 | 2 | 0 | Yes | No |
| 17728214 | INTRAVASCULAR CATHETER HAVING AN EXPANDABLE INCISING PORTION AND ABRASIVE SURFACES | April 2022 | May 2024 | Allow | 25 | 0 | 0 | No | No |
| 17660223 | OPHTHALMIC SURGICAL TOOL | April 2022 | June 2025 | Allow | 38 | 2 | 0 | No | No |
| 17716068 | ENDOPROSTHESIS DELIVERY SYSTEMS WITH DEPLOYMENT AIDS | April 2022 | September 2025 | Allow | 42 | 2 | 0 | Yes | No |
| 17704258 | DEVICE AND METHOD FOR TREATING VASCULAR OCCLUSION | March 2022 | May 2023 | Abandon | 13 | 2 | 0 | Yes | No |
| 17703200 | RECIPROCATING SERRATED BLADE FOR PRECISION DISSECTION | March 2022 | January 2026 | Allow | 46 | 2 | 0 | Yes | No |
| 17700067 | PROSTHETIC SUTURING DEVICE AND METHODS THEREOF | March 2022 | November 2024 | Allow | 32 | 1 | 0 | No | No |
| 17690774 | STENT ALIGNMENT DURING TREATMENT OF A BIFURCATION | March 2022 | April 2024 | Allow | 26 | 1 | 0 | No | No |
| 17678139 | VASCULAR STENT DEVICES AND METHODS | February 2022 | July 2025 | Allow | 40 | 4 | 0 | Yes | No |
| 17669463 | SURGICAL SUTURING INSTRUMENTS | February 2022 | April 2024 | Allow | 26 | 0 | 0 | Yes | No |
| 17590081 | OPHTHALMIC MEDICAL INSTRUMENT WITH ILLUMINATED SNARE | February 2022 | June 2022 | Allow | 5 | 1 | 0 | No | No |
| 17645372 | HYBRID POWER DELIVERY FOR SURGICAL IMPLANTS | December 2021 | February 2025 | Allow | 37 | 1 | 1 | Yes | No |
| 17595311 | APPARATUS, SYSTEM AND METHOD OF PROVIDING A SURGICAL HANDPIECE HAVING AN EMULSIFYING TIP CAPABLE OF TRANSVERSE AND LONGITUDINAL MOTION | November 2021 | July 2025 | Allow | 44 | 1 | 0 | No | No |
| 17521571 | CARDIAC VALVE REPAIR DEVICES CONFIGURED FOR PERCUTANEOUS DELIVERY | November 2021 | November 2024 | Allow | 36 | 1 | 1 | Yes | No |
| 17519533 | THROMBECTOMY APPARATUSES | November 2021 | July 2022 | Allow | 8 | 1 | 1 | Yes | No |
| 17452600 | FLUID DRIVEN VITRECTOMY PROBE | October 2021 | April 2024 | Allow | 29 | 1 | 0 | No | No |
| 17499245 | FULL EVERSION ANASTOMOSIS JUNCTURE FORMATION AND SUTURING | October 2021 | October 2025 | Allow | 48 | 0 | 1 | Yes | No |
| 17476600 | MULTI-DIAPHRAGM VITRECTOMY PROBE | September 2021 | March 2025 | Allow | 42 | 1 | 0 | Yes | No |
| 17476215 | DELIVERY AND RETRIEVAL DEVICES AND METHODS FOR SIDE-DELIVERABLE TRANSCATHETER PROSTHETIC VALVES | September 2021 | March 2022 | Allow | 6 | 0 | 1 | Yes | No |
| 17435762 | INTRAOCULAR LENS INJECTOR | September 2021 | August 2025 | Allow | 48 | 2 | 0 | Yes | No |
| 17412336 | ANCHOR DELIVERY SYSTEM | August 2021 | July 2025 | Allow | 46 | 4 | 0 | Yes | No |
| 17407809 | PERCUTANEOUS CATHETER DIRECTED INTRAVASCULAR OCCLUSION DEVICES | August 2021 | March 2025 | Allow | 43 | 2 | 0 | Yes | No |
| 17445153 | MEDICAL SYSTEMS, DEVICES, AND RELATED METHODS | August 2021 | April 2025 | Allow | 44 | 4 | 1 | Yes | No |
| 17428703 | IMPLANTATION DEVICE | August 2021 | April 2025 | Allow | 45 | 2 | 0 | Yes | No |
| 17390769 | ANNULOPLASTY RING DELIVERY CATHETERS | July 2021 | March 2025 | Allow | 43 | 1 | 0 | Yes | No |
| 17443789 | SUTURE DELIVERY SYSTEM | July 2021 | October 2024 | Abandon | 38 | 1 | 0 | No | No |
| 17384930 | Soft Suture Anchor | July 2021 | April 2025 | Abandon | 45 | 2 | 0 | Yes | No |
| 17375279 | MEDICAL TOOLS FOR CORNEAL TISSUE DELIVERY | July 2021 | April 2024 | Allow | 34 | 1 | 0 | Yes | No |
| 17364121 | MEDICAL DEVICE AND TREATMENT METHOD | June 2021 | June 2025 | Allow | 47 | 4 | 0 | No | No |
| 17360225 | MEDICAL DEVICE AND TREATMENT METHOD | June 2021 | September 2024 | Allow | 39 | 2 | 0 | Yes | No |
| 17303322 | RETRIEVAL SYSTEMS AND METHODS FOR USE THEREOF | May 2021 | January 2025 | Allow | 44 | 3 | 0 | Yes | No |
| 17292970 | CAPSULOTOMY DEVICE AND METHOD | May 2021 | March 2025 | Allow | 46 | 2 | 1 | Yes | No |
| 17302693 | SURGICAL GUIDE | May 2021 | July 2025 | Allow | 50 | 3 | 0 | Yes | No |
| 17241456 | KNOTLESS SUTURE ANCHOR SYSTEM WITH SUTURE MANAGEMENT STRUCTURE | April 2021 | June 2025 | Abandon | 49 | 4 | 1 | Yes | No |
| 17221473 | INTRAVASCULAR CATHETER HAVING AN EXPANDABLE INCISING PORTION | April 2021 | September 2024 | Allow | 42 | 2 | 0 | Yes | No |
| 17221539 | INTRAVASCULAR CATHETER HAVING AN EXPANDABLE INCISING PORTION | April 2021 | February 2025 | Allow | 47 | 3 | 0 | Yes | No |
| 17193946 | DELIVERY AND RETRIEVAL DEVICES AND METHODS FOR SIDE-DELIVERABLE TRANSCATHETER PROSTHETIC VALVES | March 2021 | August 2021 | Allow | 5 | 0 | 0 | Yes | No |
| 17181517 | Tethers For Prosthetic Mitral Valve | February 2021 | May 2024 | Abandon | 39 | 1 | 0 | No | No |
| 17181537 | PHOTON-ACTIVATABLE GEL COATED INTRACRANIAL STENT AND EMBOLIC COIL | February 2021 | December 2024 | Allow | 46 | 1 | 1 | Yes | No |
| 17167468 | PATIENT INTRODUCER ALIGNMENT | February 2021 | May 2025 | Allow | 51 | 2 | 1 | No | No |
| 17167491 | ALIGNMENT FEATURES FOR ULTRASONIC SURGICAL INSTRUMENT | February 2021 | September 2024 | Abandon | 44 | 1 | 0 | No | No |
| 17156291 | MULTI-LUMEN CATHETER DEVICES, SYSTEMS, AND METHODS OF USING THE SAME | January 2021 | February 2024 | Abandon | 37 | 1 | 0 | No | No |
| 17156265 | DEVICES, SYSTEMS AND METHODS FOR DELIVERING A PROSTHETIC MITRAL VALVE AND ANCHORING DEVICE | January 2021 | February 2024 | Allow | 37 | 1 | 0 | Yes | No |
| 17137829 | SURGICAL TOOL WITH TOOL-BASED TRANSLATION AND LOCK FOR THE SAME | December 2020 | April 2024 | Allow | 39 | 1 | 0 | No | No |
| 17132522 | IMPLANT HAVING ADJUSTABLE FILAMENT COILS | December 2020 | November 2024 | Allow | 47 | 0 | 1 | Yes | No |
| 16972973 | PLAN-SPECIFIC INSTRUMENT TEMPLATE FOR PERCUTANEOUS INTERVENTIONAL PROCEDURES | December 2020 | January 2025 | Allow | 50 | 3 | 0 | Yes | No |
| 17111148 | DELIVERY SYSTEMS FOR PROSTHETIC HEART VALVE | December 2020 | April 2023 | Allow | 29 | 0 | 0 | Yes | No |
| 17055186 | INTRAOCULAR LENS INJECTOR WITH CONTAINER | November 2020 | January 2025 | Allow | 51 | 2 | 0 | Yes | No |
| 17093401 | METHODS AND SYSTEMS FOR TREATMENT OF ACUTE ISCHEMIC STROKE | November 2020 | February 2025 | Allow | 52 | 3 | 0 | Yes | No |
| 17082904 | Implant Having Adjustable Filament Coils | October 2020 | September 2023 | Allow | 35 | 0 | 0 | Yes | No |
| 17068593 | CATHETER DESIGN FOR USE IN TREATING PLEURAL DISEASES | October 2020 | February 2024 | Allow | 40 | 2 | 0 | Yes | No |
| 17065612 | EMBOLIC COIL DELIVERY SYSTEM WITH RETRACTABLE MECHANICAL RELEASE MECHANISM | October 2020 | March 2023 | Allow | 30 | 0 | 0 | Yes | No |
| 17065693 | MEMBRANE DELAMINATION DEVICE | October 2020 | May 2024 | Allow | 43 | 1 | 0 | No | No |
| 17062183 | OPEN CHANNEL IMPLANT TOOLS AND IMPLANT TECHNIQUES UTILIZING SUCH TOOLS | October 2020 | February 2025 | Allow | 53 | 4 | 1 | Yes | No |
| 17034511 | BLOOD PRESSURE MONITORING DEVICE | September 2020 | September 2024 | Abandon | 48 | 2 | 0 | No | No |
| 16948570 | ELECTROLYTIC AND MECHANICAL DETACHMENT FOR IMPLANT DELIVERY SYSTEMS | September 2020 | August 2023 | Allow | 35 | 1 | 0 | No | No |
| 17022337 | SURGICAL INSTRUMENTS WITH ARTICULATING SHAFTS | September 2020 | March 2023 | Allow | 30 | 0 | 0 | No | No |
| 17018804 | MITRAL HEART VALVE STORAGE AND HANDLING SYSTEM | September 2020 | February 2023 | Allow | 29 | 0 | 0 | Yes | No |
| 17012678 | METHODS, COMPOSITIONS, AND DEVICES FOR THE OCCLUSION OF CAVITIES AND PASSAGEWAYS | September 2020 | January 2022 | Allow | 17 | 2 | 0 | Yes | No |
| 16999449 | RETRACTABLE CAP ACTUATION FOR AN INTRAOCULAR LENS CARTRIDGE | August 2020 | July 2023 | Allow | 35 | 0 | 0 | Yes | No |
| 16999415 | PUSH MECHANISM FOR INTERFACING A DRIVE MECHANSIM HANDPIECE WITH AN INTROACULAR LENS CARTRIDGE | August 2020 | October 2023 | Allow | 37 | 1 | 0 | Yes | No |
This analysis examines appeal outcomes and the strategic value of filing appeals for examiner IGBOKO, CHIMA U.
With a 57.1% reversal rate, the PTAB has reversed the examiner's rejections more often than affirming them. This reversal rate is in the top 25% across the USPTO, indicating that appeals are more successful here than in most other areas.
Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.
In this dataset, 33.3% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is above the USPTO average, suggesting that filing an appeal can be an effective strategy for prompting reconsideration.
✓ Appeals to PTAB show good success rates. If you have a strong case on the merits, consider fully prosecuting the appeal to a Board decision.
✓ Filing a Notice of Appeal is strategically valuable. The act of filing often prompts favorable reconsideration during the mandatory appeal conference.
Examiner IGBOKO, CHIMA U works in Art Unit 3771 and has examined 291 patent applications in our dataset. With an allowance rate of 83.5%, this examiner has an above-average tendency to allow applications. Applications typically reach final disposition in approximately 38 months.
Examiner IGBOKO, CHIMA U's allowance rate of 83.5% places them in the 58% percentile among all USPTO examiners. This examiner has an above-average tendency to allow applications.
On average, applications examined by IGBOKO, CHIMA U receive 2.41 office actions before reaching final disposition. This places the examiner in the 69% percentile for office actions issued. This examiner issues a slightly above-average number of office actions.
The median time to disposition (half-life) for applications examined by IGBOKO, CHIMA U is 38 months. This places the examiner in the 31% percentile for prosecution speed. Prosecution timelines are slightly slower than average with this examiner.
Conducting an examiner interview provides a +39.4% benefit to allowance rate for applications examined by IGBOKO, CHIMA U. This interview benefit is in the 87% percentile among all examiners. Recommendation: Interviews are highly effective with this examiner and should be strongly considered as a prosecution strategy. Per MPEP § 713.10, interviews are available at any time before the Notice of Allowance is mailed or jurisdiction transfers to the PTAB.
When applicants file an RCE with this examiner, 23.4% of applications are subsequently allowed. This success rate is in the 32% percentile among all examiners. Strategic Insight: RCEs show below-average effectiveness with this examiner. Carefully evaluate whether an RCE or continuation is the better strategy.
This examiner enters after-final amendments leading to allowance in 19.3% of cases where such amendments are filed. This entry rate is in the 23% percentile among all examiners. Strategic Recommendation: This examiner rarely enters after-final amendments compared to other examiners. You should generally plan to file an RCE or appeal rather than relying on after-final amendment entry. Per MPEP § 714.12, primary examiners have discretion in entering after-final amendments, and this examiner exercises that discretion conservatively.
When applicants request a pre-appeal conference (PAC) with this examiner, 72.7% result in withdrawal of the rejection or reopening of prosecution. This success rate is in the 60% percentile among all examiners. Strategic Recommendation: Pre-appeal conferences show above-average effectiveness with this examiner. If you have strong arguments, a PAC request may result in favorable reconsideration.
This examiner withdraws rejections or reopens prosecution in 66.7% of appeals filed. This is in the 52% percentile among all examiners. Of these withdrawals, 42.9% occur early in the appeal process (after Notice of Appeal but before Appeal Brief). Strategic Insight: This examiner shows above-average willingness to reconsider rejections during appeals. The mandatory appeal conference (MPEP § 1207.01) provides an opportunity for reconsideration.
When applicants file petitions regarding this examiner's actions, 25.5% are granted (fully or in part). This grant rate is in the 13% percentile among all examiners. Strategic Note: Petitions are rarely granted regarding this examiner's actions compared to other examiners. Ensure you have a strong procedural basis before filing a petition, as the Technology Center Director typically upholds this examiner's decisions.
Examiner's Amendments: This examiner makes examiner's amendments in 0.0% of allowed cases (in the 45% percentile). This examiner makes examiner's amendments less often than average. You may need to make most claim amendments yourself.
Quayle Actions: This examiner issues Ex Parte Quayle actions in 0.0% of allowed cases (in the 48% percentile). This examiner issues Quayle actions less often than average. Allowances may come directly without a separate action for formal matters.
Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:
Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.
No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.
Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.
Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.